Patents by Inventor Simon Carding

Simon Carding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
    Publication number: 20240335518
    Abstract: The present invention relates to a vaccine suitable for immunisation against influenza, plague or Y. pestis infection said vaccine comprising outer membrane vesicles (OMVs) and the plague vaccine including the V and/or F1 antigens of Y. pestis.
    Type: Application
    Filed: November 9, 2023
    Publication date: October 10, 2024
    Inventors: Regis Stentz, Simon Carding
  • Gut bacteria derived microvesicles for vaccine delivery
    Patent number: 12005106
    Abstract: The present invention relates to a vaccine suitable for immunisation against influenza, plague or Y. pestis infection said vaccine comprising outer membrane vesicles (OMVs) and the plague vaccine including the V and/or F1 antigens of Y. pestis.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: June 11, 2024
    Assignee: Quadram Institute Bioscience
    Inventors: Regis Stentz, Simon Carding
  • Methods and Compositions Utilising Vitamin B12 Binding
    Publication number: 20240053332
    Abstract: A composition for labelling, detection, immobilisation and/or isolation of at least one target molecule. The composition including a non-covalent affinity, coupling or binding between vitamin B12 binding protein BtuG2 and at least one bond formed between the vitamin B12 and the target molecule. The interaction between BtuG2 and vitamin B12 enables the labelling, immobilisation, isolation and/or detection of the target molecule.
    Type: Application
    Filed: November 29, 2021
    Publication date: February 15, 2024
    Inventors: Simon Carding, Rokas Juodeikis
  • DELIVERY OF BACTERIA-DERIVED OUTER MEMBRANE VESICLES
    Publication number: 20220175901
    Abstract: Pharmaceutical compositions and preparation including outer membrane vesicles (OMVs) and at least one pharmaceutically acceptable carrier wherein said OMVs are native OMVs produced by the Gram-negative commensal bacteria Bacteroides.
    Type: Application
    Filed: May 15, 2020
    Publication date: June 9, 2022
    Inventors: Simon Carding, Regis Stentz
  • GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
    Publication number: 20220105168
    Abstract: The present invention relates to a vaccine suitable for immunisation against influenza, plague or Y. pestis infection said vaccine comprising outer membrane vesicles (OMVs) and the plague vaccine including the V and/or F1 antigens of Y. pestis.
    Type: Application
    Filed: October 22, 2019
    Publication date: April 7, 2022
    Inventors: Regis Stentz, Simon Carding
  • Gut commensal bacterium and methods of using the same
    Patent number: 7988961
    Abstract: The invention provides gut commensal bacteria that have been modified to express one or more biologically active polypeptides or protiens, the bacteria includes a promoter, such as a xylanase promoter, which is induced in response to the presence of xylan in the diet and which regulates the expression of the biologically active polypeptide or protien.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: August 2, 2011
    Assignee: Plant Bioscience Limited
    Inventors: Mark Farrar, Simon Carding
  • Controlled Production and Delivery of Biologically Active Agents by Gut Bacteria
    Publication number: 20080131402
    Abstract: The invention provides gut commensal bacteria that have been modified to express one or more biologically active polypeptides or protiens, the bacteria includes a promoter, such as a xylanase promoter, which is induced in response to the presence of xylan in the diet and which regulates the expression of the biologically active polypeptide or protien.
    Type: Application
    Filed: January 24, 2006
    Publication date: June 5, 2008
    Inventors: Mark Farrar, Simon Carding